Our pioneering spirit paved the way for biotechnology in India, and we continue to apply the same spirit in finding novel approaches to improve patient outcomes today for a better tomorrow. This drives us to continuously find new ways to treat diabetes, cancer and autoimmune diseases. Our R&D focuses on prevention, alleviation and treatment and our medicines improve the lives of millions of patients in over 120 countries, by giving them access to life-saving therapies and relief.
CONTACT
Group Companies
Who we are
A Global Pioneer
We are a global biopharmaceutical company which believes that everyone has a right to affordable quality medicines.
From pipeline to production, from drug discovery to drug delivery, we bring differentiated, high-quality and affordable healthcare products to global communities.
What we do
We aim to achieve health equity.
Powered by advanced therapy platforms, our 13,500+ employees blend heart, science and creativity to make better healthcare solutions.
Our 4 global businesses include generics, biosimilars, research services and novel biologics. They represent Biocon’s risk-balanced strategy, underpinned by agile network connections, a robust pipeline and a timely ‘emerging markets’ orientation. We have leveraged India’s value advantage of unmatched scientific talent and cost-competitive manufacturing to deliver scale, speed and quality. By making medicines more easily accessible for patients across the globe, we’re working towards achieving health equity.
Our purpose
We are committed to providing everyone, everywhere, affordable access to a speciality portfolio of medicines.
We are steadfastly investing in developing novel therapies for diabetes, oncology and immunology. We are strengthening our global reach and economies of scale.
Corporate Overview
Download Our Integrated
Annual Report 2024
The Multiplier Effect.
Our Businesses
Path-breaking offerings. Far reaching impact.
GENERICS
BIOSIMILARS
RESEARCH SERVICES
NOVEL BIOLOGICS
Factsheet
Biocon at a glance
Advancing
biotechnology for
biotechnology for
40+
years
Improving lives
across
across
120+
countries
Talented, dedicated
workforce of
workforce of
16,300+
employees
Factsheet
Biocon at a glance
Advancing
biotechnology for
biotechnology for
40+
years
Improving lives
across
across
120+
countries
Talented, dedicated
workforce of
workforce of
12,000+
employees
A culture of innovation
Biocon at a glance
299
Patents Granted
(Small Molecules)
Till end of CY 21
(Small Molecules)
Till end of CY 21
982
Patents Granted
(Biologics)
Till end of CY 21
(Biologics)
Till end of CY 21
25+
cGMP Approvals
international
regulatory agencies
international
regulatory agencies
8
Biologics were taken
from 'Lab to Market':
2 Novels and
6 Biosimilars
from 'Lab to Market':
2 Novels and
6 Biosimilars
vision
To enhance global healthcare through innovative and affordable biopharmaceuticals for patients, partners and healthcare systems across the globe.
values
Integrity and ethical behaviour
Performance-driven work culture
Value creation through innovation and differentiation
Quality through compliance and best practices
Collaboration, teamwork and mutual respect
mission
To be an integrated biotechnology enterprise of global distinction. Essential to this mission is excellence in:
Intellectual asset creation through discovery, research and development
State-of-the-art manufacturing capabilities
Internationally benchmarked quality and regulatory systems
New medical insight through disease-specific clinical research
Customer relationship through outstanding products and services
Human resource development through training, mentoring and empowering
Management of research and business partnerships
Know more
about us
CORPORATE GOVERNANCE
KEY THERAPEUTIC AREAS
RESEARCH SERVICES
OUR CULTURE
